I've received numerous emails with links to the 15
Post# of 9122
Posted On: 02/25/2015 5:57:26 PM
I've received numerous emails with links to the 15-min Ebola test that was in the news yesterday. Investors need to keep a few important things in mind.
1) N-Assay was developed for bacteria. Bacteria is still the Company's primary focus last I checked.
2) It was thought the N-Assay could be applied to viruses. The Company was successful in getting proof of concept. Lots more work required to get it to commercial form -- work that is to be mostly a partner company's burden.
3) All these quick-result Ebola tests are used after symptoms begin to show.
For example, you find out you have been exposed to someone with Ebola. You have to stay in quarantine for 3 weeks waiting to see if any symptoms develop. Say you develop symptoms -- could be anything. You use one of these quick test diagnostic tools to determine what exactly you have.
With the N-Asssay and its much higher sensitivity, you may be able to determine whether you have Ebola sometime before you develop actual symptoms. This would be a much more effective tool at preventing the spread of the disease and reduce costs associated with a full-term quarantine.
Looks to me that the manipulators decided to focus investors on this 15-minute test by someone other than Nanologix to be their current champion.
1) N-Assay was developed for bacteria. Bacteria is still the Company's primary focus last I checked.
2) It was thought the N-Assay could be applied to viruses. The Company was successful in getting proof of concept. Lots more work required to get it to commercial form -- work that is to be mostly a partner company's burden.
3) All these quick-result Ebola tests are used after symptoms begin to show.
For example, you find out you have been exposed to someone with Ebola. You have to stay in quarantine for 3 weeks waiting to see if any symptoms develop. Say you develop symptoms -- could be anything. You use one of these quick test diagnostic tools to determine what exactly you have.
With the N-Asssay and its much higher sensitivity, you may be able to determine whether you have Ebola sometime before you develop actual symptoms. This would be a much more effective tool at preventing the spread of the disease and reduce costs associated with a full-term quarantine.
Looks to me that the manipulators decided to focus investors on this 15-minute test by someone other than Nanologix to be their current champion.
(0)
(0)Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼